clinical trial management
The company will use the funds to expand in Asian and U.S. markets, advance its AI algorithms and grow its workforce.
The California-based company will put the funds toward its workforce, growing its data and further investing in R&D initiatives and engineering capabilities.
The partners will develop a database for academics and biopharma researchers to acquire insights to help advance cancer-focused research.